Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor
US7960410B2 · kind B2 · utility
1Cited by
19References
40Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 10, 2005 |
| Grant date | Jun 14, 2011 |
| Priority date | — |
| Expiry date | Aug 14, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of ketoconazole and derivatives having a corresponding biological activity, and combinations thereof, in the treatment of abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.